Skip to main content
. 2022 Feb 28;10(3):376. doi: 10.3390/vaccines10030376

Figure 1.

Figure 1

Association between IBD treatment and COVID-19 severity. (A) Number of IBD patients with various degrees of COVID-19 severity comparing biological therapy and non-biological therapy. (B) Outcome of COVID-19 in patients with IBD, comparing biological therapy and non-biological therapy. The p-value is based on a Pearson Chi-square test comparing patient distribution between groups (biological therapy and non-biological therapy), with p < 0.001 (***) in all degrees of COVID-19 severity and outcomes.